Immune activation and cardiovascular disease in chronic HIV infection.
about
Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan AfricaImmune activation and HIV: an enduring relationshipTransgender populations and HIV: unique risks, challenges and opportunities.Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyLower coronary plaque burden in patients with HIV presenting with acute coronary syndrome.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV.Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients.Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US.Early vascular aging in the HIV infected: Is arterial stiffness assessment the ideal tool?Physical fitness characteristics of active duty US Air Force members with HIV infection.Special considerations concerning the use of antiretroviral drugs in children.Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study.Belatacept Conversion in an HIV-Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function.The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery.People Living With HIV: Implications for Rehabilitation Nurses.
P2860
Q36290172-03EF6596-FF28-4DD6-B1CC-6FF94E29EF59Q36565474-C7AE9495-1ED1-4E4C-98DD-71C17A164148Q37136266-AEA72C86-4361-43E8-822A-9E7B05EFECD7Q37513027-23B16447-88DA-4BE7-8EBD-CCE9968526EDQ37587386-5274989B-2488-4B90-AE22-85831D5B931FQ39165028-9DD5F991-1FF6-40C7-BAB3-966CB0153F0FQ40132566-34852702-F4B0-43D9-8E40-9F016390E53EQ40147950-D2AAFF8C-C5B9-4BD3-B57E-6C992B5E0D89Q40163303-2BA3236F-3278-4024-9A21-531BB72446E0Q40217543-21C01D00-51E1-4F01-A19A-AD6DA1DD4D52Q40446793-51B0619B-2C75-4E9A-BE67-DCB7869D43E2Q40535139-5046DBFA-90F0-414C-8FDA-ACFB3C79830CQ47700814-737D2F57-B2DA-423F-B7FE-A1BE0A278658Q48013543-08E02FC4-502E-49CC-A0BD-5610AE30159AQ50282032-D4CB53FC-855F-4B11-A3A9-465EA8576627Q55492735-6D6D6FAB-32FA-45D1-AB12-84DD60903763
P2860
Immune activation and cardiovascular disease in chronic HIV infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immune activation and cardiovascular disease in chronic HIV infection.
@ast
Immune activation and cardiovascular disease in chronic HIV infection.
@en
type
label
Immune activation and cardiovascular disease in chronic HIV infection.
@ast
Immune activation and cardiovascular disease in chronic HIV infection.
@en
prefLabel
Immune activation and cardiovascular disease in chronic HIV infection.
@ast
Immune activation and cardiovascular disease in chronic HIV infection.
@en
P2093
P2860
P1476
Immune activation and cardiovascular disease in chronic HIV infection.
@en
P2093
Chris T Longenecker
Claire Sullivan
Jason V Baker
P2860
P304
P356
10.1097/COH.0000000000000227
P577
2015-11-21T00:00:00Z